[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2012008765A3 - Pharmaceutical composition for treating or preventing cancer - Google Patents

Pharmaceutical composition for treating or preventing cancer Download PDF

Info

Publication number
WO2012008765A3
WO2012008765A3 PCT/KR2011/005170 KR2011005170W WO2012008765A3 WO 2012008765 A3 WO2012008765 A3 WO 2012008765A3 KR 2011005170 W KR2011005170 W KR 2011005170W WO 2012008765 A3 WO2012008765 A3 WO 2012008765A3
Authority
WO
WIPO (PCT)
Prior art keywords
treating
pharmaceutical composition
preventing cancer
compound
chemical formula
Prior art date
Application number
PCT/KR2011/005170
Other languages
French (fr)
Korean (ko)
Other versions
WO2012008765A2 (en
Inventor
이지훈
Original Assignee
Lee Gee-Hwoon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020110017286A external-priority patent/KR20120006923A/en
Application filed by Lee Gee-Hwoon filed Critical Lee Gee-Hwoon
Priority to JP2013519594A priority Critical patent/JP2013530251A/en
Publication of WO2012008765A2 publication Critical patent/WO2012008765A2/en
Publication of WO2012008765A3 publication Critical patent/WO2012008765A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to the compound of chemical formula I, to the pharmaceutically acceptable salts thereof or hydrates thereof, to a pharmaceutical composition containing the compound as an active ingredient for treating or preventing cancer, and to a method for preparing the compound of chemical formula I.
PCT/KR2011/005170 2010-07-13 2011-07-13 Pharmaceutical composition for treating or preventing cancer WO2012008765A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013519594A JP2013530251A (en) 2010-07-13 2011-07-13 Pharmaceutical composition for treatment or prevention of cancer {PHARMACEUTICALCOMPOSITIONFORTREATINGORPREVINGTINGCANCER}

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
KR10-2010-0067614 2010-07-13
KR20100067614 2010-07-13
KR10-2011-0017286 2011-02-25
KR1020110017286A KR20120006923A (en) 2010-07-13 2011-02-25 Pharmaceutical composition for treating or preventing cancer
KR10-2011-0069379 2011-07-13
KR1020110069379A KR101522712B1 (en) 2010-07-13 2011-07-13 Pharmaceutical composition for treating or preventing cancer

Publications (2)

Publication Number Publication Date
WO2012008765A2 WO2012008765A2 (en) 2012-01-19
WO2012008765A3 true WO2012008765A3 (en) 2012-05-31

Family

ID=45469930

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/005170 WO2012008765A2 (en) 2010-07-13 2011-07-13 Pharmaceutical composition for treating or preventing cancer

Country Status (1)

Country Link
WO (1) WO2012008765A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070167515A1 (en) * 2004-01-14 2007-07-19 Centre National De La Recherche Scientifique (Cnrs) Pyranone derivatives useful for treating cancer
KR20090085455A (en) * 2008-02-04 2009-08-07 에스케이케미칼주식회사 5-aryl-2-pyrone derivatives with anti-cancer activity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070167515A1 (en) * 2004-01-14 2007-07-19 Centre National De La Recherche Scientifique (Cnrs) Pyranone derivatives useful for treating cancer
KR20090085455A (en) * 2008-02-04 2009-08-07 에스케이케미칼주식회사 5-aryl-2-pyrone derivatives with anti-cancer activity

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GOEL, ATUL ET AL.: "A vicarious synthesis of unsymmetrical meta- and paraterphenyls from 2H-pyran-2-ones.", TETRAHEDRON LETTERS, vol. 46, 2005, pages 8487 - 8491 *
KASAPLAR, PINAR ET AL.: "6-Bicycloaryl substituted (S)- and (R)-5,6-dihydro-2H-pyran-2-ones: Asymmetric synthesis, and anti-proliferative properties.", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 17, 2009, pages 311 - 318, XP025876000, DOI: doi:10.1016/j.bmc.2008.10.069 *
NARASIMHULU, MANCHALA ET AL.: "Stereoselective synthesis of (6S) and (6R)-5,6-dihydro-6- [(2R)-2-hydroxy-6-phenylhexyl]-2H-pyran-2-one and their cytotoxic activity against cancer cell lines.", TETRAHEDRON, vol. 65, 2009, pages 2989 - 2994, XP025970406, DOI: doi:10.1016/j.tet.2009.01.101 *

Also Published As

Publication number Publication date
WO2012008765A2 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
WO2010108074A3 (en) Inhibitors of pi3 kinase
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
IN2014KN00948A (en)
TN2012000248A1 (en) Novel spiropiperidine compounds
MY193277A (en) Certain amino-pyrimidines, compositions thereof, and methods for their use
MY170935A (en) Neprilysin inhibitors
EP4219465A3 (en) Prmt5 inhibitors and uses thereof
BR112012026767A2 (en) compound, pharmaceutically acceptable salt of a compound, pharmaceutical composition, method for treating or preventing disorders, and use of a compound or salt
MX2011011335A (en) Inhibitors of pi3 kinase and / or mtor.
MX2013006802A (en) Neprilysin inhibitors.
MD4602B1 (en) Inhibitors of hepatitis C virus
MX2013007336A (en) Bi-heteroaryl compounds as vps34 inhibitors.
MY165087A (en) Neprilysin inhibitors
MY183312A (en) Pharmaceutical formulation
MY187718A (en) Pharmaceutical formulations
WO2012135615A3 (en) Enopeptins, uses thereof, and methods of synthesis thereto
WO2014036502A3 (en) Tetracycline compounds
WO2012118308A3 (en) Composition for preventing and treating cardiovascular diseases, containing pyrazole derivative
WO2013177534A3 (en) New salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
WO2012140596A8 (en) Glycoside derivatives and uses thereof
ZA201500362B (en) Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
IN2012DN04868A (en)
WO2012118309A3 (en) Pyrazole derivatives, preparation method thereof, and composition for preventing and treating osteoporosis containing same
MX2016006667A (en) Pyrrolopyrrolone derivatives and their use as bet inhibitors.
WO2013062332A3 (en) Vascular anti-aging composition including syringaresinol

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11807050

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2013519594

Country of ref document: JP

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 11807050

Country of ref document: EP

Kind code of ref document: A2